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Addiction to prescription 
and over-the-counter 
(OTC) medicines is a 
hidden, little-researched 
chronic illness – which 
could be significantly countered by 
destigmatisation, ‘up-scheduling’ certain 
medications, creating a single electronic 
database across dispensaries and boosting 
doctor awareness regarding long-term or 
repeat prescriptions. This is according 
to Dr Volker Hitzeroth, President of 
the South African Addiction Medicine 
Society and convenor of the addictions 
sub-group of the South African Society of 
Psychiatrists. 
Hitzeroth says low doctor awareness and 
sparse use of alternatives to addictive pain-
killing opioids add significantly to addiction. 
Since the only indication of the problem’s 
spread and depth nationally is a dated 
(2003) study of 23 specialist substance abuse 
treatment centres in Cape Town,[1] addiction 
treatment specialists have to lean heavily 
on an alarming 2012 United Nations World 
Drug report. It says that worldwide, up to 
36 million people are dependent on opioids, 
nearly half of those seeking treatment for 
prescription medicine dependence reporting 
the use of opioid-containing painkillers. 
This latter estimate is extrapolated to South 
Africa and used as a basis for designing 
holistic countermeasures.
Suspected prevalence: ‘massive’
Researchers and members of the South 
African Community Epidemiology Network 
on Drug Abuse (SACENDU) found that over 
two years (1998 to 2000) 7.8% of the 9 063 
cases recorded by specialist treatment centres 
in Cape Town reported OTC, prescription or 
‘unspecified’ medicines as the primary or 
secondary substance of abuse.  
‘These are just the ones we know about,’ 
said Hitzeroth. ‘It’s a very grey area – by 
the nature of these enquiries people hide 
information, it’s difficult to own up; they 
don’t want to or don’t know it’s a problem. 
The whole field is clouded in mystery … 
but we suspect we actually have a massive 
prevalence.’ 
While the SACENDU study discovered 
benzodiazepines to be the most widely 
misused medicines in Cape Town (consistent 
with USA and European studies) and 
that more (middle-aged, higher income) 
women than men reported them as their 
primary substance of abuse, its authors 
question whether findings derived from a 
treatment context reflect medicine misuse 
in the general population. Like Hitzeroth, 
they speculate that OTC and prescription 
medicine abuse is ‘far greater than we have 
observed’. Hitzeroth sees a wide range of 
OTC and prescription medicine addicts 
(including several healthcare professionals). 
He says that in spite of the guidelines and 
regulations surrounding the prescription of 
pain medicines, and the accepted wisdom 
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of ‘prescribing  short-term, at lower doses’, 
doctors continue to give three- and six-
month scripts for Adcodol, Syndol, 
Myprodol and their associated generics – 
all of which contain codeine – and for 
sleeping tablets that use benzodiazepines 
(particularly alprazolam).
Mitigation and alternatives
Hitzeroth is registered in the United 
Kingdom as a psychiatrist with a sub-
specialty in addictions (currently no such 
specialty is available at the HPCSA). He 
lectures in the subject and has written a 
book, The End of Addiction.
‘The primary problem in this particular 
field is lack of awareness,’ he says. ‘Doctors, 
pharmacists and patients are generally 
not very aware. When I see patients 
and families and ask if they knew the 
medication was addictive, they all say no. 
Then they’re surprised that the drug has 
been prescribed non-stop for three years 
by various doctors.’ Hitzeroth says doctors 
are under pressure to get patients better 
quickly and have limited time with each 
patient, while patients are demanding and 
pharmacists are under ‘business pressure’. 
‘I’ve interviewed pharmacists who say if 
they don’t give Adcodol the guy next door 
will,’ he adds.
One mitigating action would be to limit 
the availability of the ‘known suspect’ 
medicines via smaller packs and lower 
dosages, as well as up-scheduling the most 
abused drugs. A ‘really useful’ intervention 
would be to set up an electronic database, 
enabling all pharmacists and dispensing 
doctors/nurses to instantly view any patient’s 
purchasing history. With patient consent, 
doctors in a group practice (including 
locums) could also share information about 
a single patient, thus avoiding becoming 
unwitting participants in a patient’s drug 
habit. Hitzeroth said there are ‘probably a 
handful of rotten doctors not doing the right 
thing and they need to be dealt with. If a 
patient or family are concerned they should 
report them with alacrity.’
Asked to give alternatives to prescription 
sleeping tablets, he listed antihistamines, 
certain sedating anti-depressants, a selection 
of low dose anti-psychotic medicines 
and a wide range of herbal remedies 
such as valerian and melatonin. Non-
pharmacological management, such as sleep 
hygiene, is seldom used: ‘You establish a 
bedtime routine, don’t exercise, drink alcohol 
or smoke before sleeping and avoid daytime 
sleeps,’ Hitzeroth explained. You use your 
bed only for sleeping and sexual recreation 
– not for watching TV, listening to music, 
playing DVD games or kids playing. A 
bedroom needs to be a calm, relaxing, quiet, 
pleasant environment with a comfortable 
temperature.’ 
Lessons from overseas
Hitzeroth says working overseas opened his 
eyes. ‘We’re far behind the rest of the world 
in terms of our approach to the treatment 
of addictions. I want to put addiction and 
treatment on the agenda, teach people. 
We also have a lot of cowboys in South 
Africa, less knowledgeable practitioners 
whose hearts are in the right place but who 
intervene in the wrong way, giving wrong 
prescriptions – and we’re not up to scratch 
with the latest evidence base.’ 
The modern approach is to see addiction 
as a neuro-biological disease, not dissimilar 
to chronic relapsing illnesses like HIV or 
diabetes. He said one recent study[2] revealed 
that outcomes for addictions were no 
worse than for other chronic illnesses. ‘Yet 
everybody stigmatises addiction. We must 
treat it as a biopsychosocial illness, like all 
the others, and involve psychologists, social 
workers – whoever is needed for a holistic 
approach.’ 
He said pointers to addiction include 
repeated requests for specific codeine-
containing drugs, complaints of constant 
ongoing, ‘unrelieved’ pain (most abused 
medicines are for acute pain), stress 
and anxiety, and ‘doctor-shopping and 
pharmacy-hopping’ (different pharmacists 
being presented with different scripts 
for the same or similar medicine from 
different doctors). ‘I’ve also had three cases 
where pharmacists actually picked up my 
forged signature and called me,’ Hitzeroth 
warned.
Interventions actually work
The biggest upside, however, is that unlike 
those addicted to heroin, ‘tik’ or crack 
cocaine, OTC and prescription medicine-
dependent patients are more ready to 
quit, and respond ‘very well’ once a good 
doctor-patient rapport is established and 
some motivational work begun. ‘They are 
very grateful that we can get them off,’ says 
Hitzeroth. ‘If they’re really motivated we 
can get them off within a matter of weeks, 
occasionally months, depending on dosages 
and the meds involved. I have a whole 
range of patients I’m doing this with. It 
doesn’t need to be a black hole that doctors 
must avoid and don’t know how to manage. 
The core message is awareness: Ask the 
question (of the patient), engage, educate 
and motivate!’
Hitzeroth confirmed the SACENDU 
research profile of this category of drug-
dependent persons (OTC/PM): traditional 
middle to upper class, living in ‘leafy 
suburbs’. However, ‘We’re seeing more 
and more professional, qualified working 
people and more with tertiary education, 
and, sadly, the previously underprivileged.’ 
He explained that because OTCs and 
prescription medicines are so much cheaper 
than illicit drugs, even people who can’t 
afford a consultation with a private doctor 
get them over the counter. A stereotypical 
profile of an OTC/PM-dependent person 
would be a middle-aged, successful white 
woman (with other groups fast catching up), 
perhaps also suffering pain, depression and/
or anxiety. 
Hitzeroth has reassuring words for 
medical professionals with drug habits, 
many of whom are self-prescribing and 
believe themselves to be ‘in control’. ‘Yes, 
the HPCSA guidelines say colleagues are 
Dr Volker Hitzeroth, President of the South 
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obliged to report them, but the overall 
purpose is not to deregister them but to 
treat them and keep them in the profession. 
My experience is they don’t need to fear for 
their licences if they co-operate. The best 
route is to self-report and get help from the 
Medical Protection Society or similar outfit 
– often it’s marital, financial or work-related 
problems and lives start falling apart. The 
first step is to get rid of what’s being used to 
numb the (emotional) pain.’
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